Cancer in neonates and infants

Medical and Pediatric Oncology

Volumn 41, Issue 1, 2003, Pages 7-9

  Vasilatou Kosmidis, Helen ^a,b,c  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^b Department of Oncology ^*  (Greece)

^c Aglaia Kyriakou Children's Hospital   (Greece)

Author keywords

Childhood cancer; Epidemiology; Infants with cancer; Newborns with cancer

Indexed keywords

CARCINOGENESIS; CHILDHOOD CANCER; CHROMOSOME TRANSLOCATION; COLON POLYPOSIS; DISEASE TRANSMISSION; DOWN SYNDROME; EMBRYO DEVELOPMENT; GENETIC COUNSELING; GENETIC PREDISPOSITION; GEOGRAPHIC DISTRIBUTION; HEPATOBLASTOMA; HUMAN; LEUKEMIA; MELANOMA; NEPHROBLASTOMA; PRIORITY JOURNAL; RACE DIFFERENCE; RETINOBLASTOMA; REVIEW; TERATOGENESIS; VERTICAL TRANSMISSION; CANCER REGISTRY; CENTRAL NERVOUS SYSTEM TUMOR; INCIDENCE; INFANT; INFANT MORTALITY; KIDNEY TUMOR; MORTALITY; NEOPLASM; NEUROBLASTOMA; NEWBORN; PRESCHOOL CHILD; PREVALENCE; SARCOMA; UNITED STATES;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; INFANT MORTALITY; INFANT, NEWBORN; KIDNEY NEOPLASMS; LEUKEMIA; NEOPLASMS; NEUROBLASTOMA; PREVALENCE; SARCOMA; SEER PROGRAM; UNITED STATES;

EID: 0037734193     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10153     Document Type: Review

References (28)

1. Gurney JG, Ross JA, Wall DA, et al. Infant cancer in the US: Histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol 1997;19:428-432.
2. Bolande RP. Neoplasia of early life and its relationship to teratogenesis. Perspect Pediatr Pathol 1976;3:145-151.
3. Coffin CM, Dehner LP. Soft tissue tumors in first year of life. Pediat Pathol 1990;10:509-526.
4. Kenney LB, Reaman GH. Special considerations for the infant with cancer. In: Philip A Pizzo, David G Poplack, editors. Principles and practice of pediatric oncology. 3rd edition. Philadelphia: Lippincott-Raven Publishers; 1997. p 343-373.
5. Kaye SA, Robison LL, Smithson WA, et al. Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer 1991;68:1351-1355.
6. Knudson AG. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823.
7. Li FP, Fraumeni JF, Jr. Soft tissue sarcomas, breast cancer and other neoplasms: A familial syndrome? Ann Int Med 1969;71:747-752.
8. Malkin D. Germline p53 mutations and heritable cancer. Ann Rev Genet 1984;28:443-465.
9. Cramblett MG, Friedman JL, Najjar S. Leukemia in an infant born of a mother with leukemia. N Engl J Med 1958;259:727-729.
10. Cavell B. Transplancental metastasis of malignant melanoma. Acta Paediatr Scand (Suppl) 1963;146:37-40.
11. Reaman GH. Special considerations for the infant with cancer. In: Philip A Pizzo, David G Poplack, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott-Raven Publishers; copyright 1989. p 263-274.
12. Birch JM, Blair V. The epidemiology of infant cancers. Br J Cancer 1992;66:S2-S4.
13. Gurney JG, Severson RK, Davis S, et al. Incidence of cancer in children in the United States Cancer 1995;75:2186-2195.
14. Morgan E, Baum E, Breslow N, et al. Chemotherapy related toxicity in infants treated according to the second National Wilms' Tumor Study. J Clin Oncol 1988;6:51-55.
15. Bleyer WA. Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age related pharmacokinetics. Cancer Treat Rep 1977;61:1419-1425.
16. Murphy GM, Singer E. Bile acid metabolism in infants and children. Gut 1974;15:151-162.
17. Friis-Hansen B. Body water compartments in children: Changes during growth and related changes in body composition. Pediatrics 1961;28:169-181.
18. Corn BW, Goldwein JW, Evans I, D'Angio GJ. Outcomes in low-risk babies treated with half-dose chemotherapy according to the Third National Wilms' Tumor Study. J Clin Oncol 1992;10:1305-1309.
19. Greaves MF. Infant leukaemia biology, aetiology and treatment (Workshop report). Leukemia 1996;10:372-377.
20. Ross JA, Davies SM, Potter JD, et al. Epidemiology of childhood leukemia with a focus on infants. Epidemiol Rev 1994;16:243-272.
21. Gill Super HJ, McCabe NR, Thirman MJ, et al. Rearrangement of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 1993;82:3705-3711.
22. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993;81:2237-2251.
23. Romana SP, Poirel H, Leconiat M, et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995;86:4263-4269.
24. Greaves M. Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 1999;35:1941-1953.
25. Greaves MF, Alexander FE. An infectious origin for common acute lymphoblastic leukaemia in childhood? Leukemia 1993;7:349-360.
26. Kinlen LJ. Epidemiological evidence for an infective basis in childhood leukaemia Br J Cancer 1995;71:1-5.
27. Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 1997;94:13950-13954.
28. Wiemels JL, Ford AM, Bennett CA, et al. Direct evidence for a prenatal origin of TEL-AML1 gene fusions in paediatric leukaemia. Blood 1998;92(Suppl. 1):68-69 (abstract no. 277).